COVID-19 Impact on Global Pertuzumab, Market Insights and Forecast to 2026
Pertuzumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pertuzumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pertuzumab market is segmented into
The Pertuzumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pertuzumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pertuzumab Market Share Analysis
Pertuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertuzumab business, the date to enter into the Pertuzumab market, Pertuzumab product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Pertuzumab market is segmented into
- Human Source
- Animal Source
- Hospital
- Medical Center
The Pertuzumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pertuzumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pertuzumab Market Share Analysis
Pertuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertuzumab business, the date to enter into the Pertuzumab market, Pertuzumab product introduction, recent developments, etc.
The major vendors covered:
- Novartis AG
- Pfizer
- Abnova Corporation
- InvivoGen
- Celltrion
- Biocon Limited
- Bio-Techne
1 STUDY COVERAGE
1.1 Pertuzumab Product Introduction
1.2 Market Segments
1.3 Key Pertuzumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pertuzumab Market Size Growth Rate by Type
1.4.2 Human Source
1.4.3 Animal Source
1.5 Market by Application
1.5.1 Global Pertuzumab Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Center
1.6 Coronavirus Disease 2019 (Covid-19): Pertuzumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Pertuzumab Industry
1.6.1.1 Pertuzumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pertuzumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pertuzumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pertuzumab Market Size Estimates and Forecasts
2.1.1 Global Pertuzumab Revenue 2015-2026
2.1.2 Global Pertuzumab Sales 2015-2026
2.2 Pertuzumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Pertuzumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pertuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PERTUZUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pertuzumab Sales by Manufacturers
3.1.1 Pertuzumab Sales by Manufacturers (2015-2020)
3.1.2 Pertuzumab Sales Market Share by Manufacturers (2015-2020)
3.2 Pertuzumab Revenue by Manufacturers
3.2.1 Pertuzumab Revenue by Manufacturers (2015-2020)
3.2.2 Pertuzumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pertuzumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pertuzumab Revenue in 2019
3.2.5 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pertuzumab Price by Manufacturers
3.4 Pertuzumab Manufacturing Base Distribution, Product Types
3.4.1 Pertuzumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pertuzumab Product Type
3.4.3 Date of International Manufacturers Enter into Pertuzumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pertuzumab Market Size by Type (2015-2020)
4.1.1 Global Pertuzumab Sales by Type (2015-2020)
4.1.2 Global Pertuzumab Revenue by Type (2015-2020)
4.1.3 Pertuzumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pertuzumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Pertuzumab Sales Forecast by Type (2021-2026)
4.2.2 Global Pertuzumab Revenue Forecast by Type (2021-2026)
4.2.3 Pertuzumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pertuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pertuzumab Market Size by Application (2015-2020)
5.1.1 Global Pertuzumab Sales by Application (2015-2020)
5.1.2 Global Pertuzumab Revenue by Application (2015-2020)
5.1.3 Pertuzumab Price by Application (2015-2020)
5.2 Pertuzumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Pertuzumab Sales Forecast by Application (2021-2026)
5.2.2 Global Pertuzumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Pertuzumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pertuzumab by Country
6.1.1 North America Pertuzumab Sales by Country
6.1.2 North America Pertuzumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pertuzumab Market Facts & Figures by Type
6.3 North America Pertuzumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pertuzumab by Country
7.1.1 Europe Pertuzumab Sales by Country
7.1.2 Europe Pertuzumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pertuzumab Market Facts & Figures by Type
7.3 Europe Pertuzumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pertuzumab by Region
8.1.1 Asia Pacific Pertuzumab Sales by Region
8.1.2 Asia Pacific Pertuzumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pertuzumab Market Facts & Figures by Type
8.3 Asia Pacific Pertuzumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pertuzumab by Country
9.1.1 Latin America Pertuzumab Sales by Country
9.1.2 Latin America Pertuzumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pertuzumab Market Facts & Figures by Type
9.3 Central & South America Pertuzumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pertuzumab by Country
10.1.1 Middle East and Africa Pertuzumab Sales by Country
10.1.2 Middle East and Africa Pertuzumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pertuzumab Market Facts & Figures by Type
10.3 Middle East and Africa Pertuzumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description, Business Overview and Total Revenue
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Pertuzumab Products Offered
11.1.5 Novartis AG Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Pertuzumab Products Offered
11.2.5 Pfizer Recent Development
11.3 Abnova Corporation
11.3.1 Abnova Corporation Corporation Information
11.3.2 Abnova Corporation Description, Business Overview and Total Revenue
11.3.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abnova Corporation Pertuzumab Products Offered
11.3.5 Abnova Corporation Recent Development
11.4 InvivoGen
11.4.1 InvivoGen Corporation Information
11.4.2 InvivoGen Description, Business Overview and Total Revenue
11.4.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 InvivoGen Pertuzumab Products Offered
11.4.5 InvivoGen Recent Development
11.5 Celltrion
11.5.1 Celltrion Corporation Information
11.5.2 Celltrion Description, Business Overview and Total Revenue
11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celltrion Pertuzumab Products Offered
11.5.5 Celltrion Recent Development
11.6 Biocon Limited
11.6.1 Biocon Limited Corporation Information
11.6.2 Biocon Limited Description, Business Overview and Total Revenue
11.6.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biocon Limited Pertuzumab Products Offered
11.6.5 Biocon Limited Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Corporation Information
11.7.2 Bio-Techne Description, Business Overview and Total Revenue
11.7.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bio-Techne Pertuzumab Products Offered
11.7.5 Bio-Techne Recent Development
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description, Business Overview and Total Revenue
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Pertuzumab Products Offered
11.1.5 Novartis AG Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pertuzumab Market Estimates and Projections by Region
12.1.1 Global Pertuzumab Sales Forecast by Regions 2021-2026
12.1.2 Global Pertuzumab Revenue Forecast by Regions 2021-2026
12.2 North America Pertuzumab Market Size Forecast (2021-2026)
12.2.1 North America: Pertuzumab Sales Forecast (2021-2026)
12.2.2 North America: Pertuzumab Revenue Forecast (2021-2026)
12.2.3 North America: Pertuzumab Market Size Forecast by Country (2021-2026)
12.3 Europe Pertuzumab Market Size Forecast (2021-2026)
12.3.1 Europe: Pertuzumab Sales Forecast (2021-2026)
12.3.2 Europe: Pertuzumab Revenue Forecast (2021-2026)
12.3.3 Europe: Pertuzumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pertuzumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pertuzumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pertuzumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pertuzumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Pertuzumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Pertuzumab Sales Forecast (2021-2026)
12.5.2 Latin America: Pertuzumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Pertuzumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pertuzumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pertuzumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pertuzumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pertuzumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pertuzumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pertuzumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pertuzumab Product Introduction
1.2 Market Segments
1.3 Key Pertuzumab Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pertuzumab Market Size Growth Rate by Type
1.4.2 Human Source
1.4.3 Animal Source
1.5 Market by Application
1.5.1 Global Pertuzumab Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Center
1.6 Coronavirus Disease 2019 (Covid-19): Pertuzumab Industry Impact
1.6.1 How the Covid-19 is Affecting the Pertuzumab Industry
1.6.1.1 Pertuzumab Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pertuzumab Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pertuzumab Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pertuzumab Market Size Estimates and Forecasts
2.1.1 Global Pertuzumab Revenue 2015-2026
2.1.2 Global Pertuzumab Sales 2015-2026
2.2 Pertuzumab Market Size by Region: 2020 Versus 2026
2.2.1 Global Pertuzumab Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pertuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PERTUZUMAB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pertuzumab Sales by Manufacturers
3.1.1 Pertuzumab Sales by Manufacturers (2015-2020)
3.1.2 Pertuzumab Sales Market Share by Manufacturers (2015-2020)
3.2 Pertuzumab Revenue by Manufacturers
3.2.1 Pertuzumab Revenue by Manufacturers (2015-2020)
3.2.2 Pertuzumab Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pertuzumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pertuzumab Revenue in 2019
3.2.5 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pertuzumab Price by Manufacturers
3.4 Pertuzumab Manufacturing Base Distribution, Product Types
3.4.1 Pertuzumab Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pertuzumab Product Type
3.4.3 Date of International Manufacturers Enter into Pertuzumab Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pertuzumab Market Size by Type (2015-2020)
4.1.1 Global Pertuzumab Sales by Type (2015-2020)
4.1.2 Global Pertuzumab Revenue by Type (2015-2020)
4.1.3 Pertuzumab Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pertuzumab Market Size Forecast by Type (2021-2026)
4.2.1 Global Pertuzumab Sales Forecast by Type (2021-2026)
4.2.2 Global Pertuzumab Revenue Forecast by Type (2021-2026)
4.2.3 Pertuzumab Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pertuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pertuzumab Market Size by Application (2015-2020)
5.1.1 Global Pertuzumab Sales by Application (2015-2020)
5.1.2 Global Pertuzumab Revenue by Application (2015-2020)
5.1.3 Pertuzumab Price by Application (2015-2020)
5.2 Pertuzumab Market Size Forecast by Application (2021-2026)
5.2.1 Global Pertuzumab Sales Forecast by Application (2021-2026)
5.2.2 Global Pertuzumab Revenue Forecast by Application (2021-2026)
5.2.3 Global Pertuzumab Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pertuzumab by Country
6.1.1 North America Pertuzumab Sales by Country
6.1.2 North America Pertuzumab Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pertuzumab Market Facts & Figures by Type
6.3 North America Pertuzumab Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pertuzumab by Country
7.1.1 Europe Pertuzumab Sales by Country
7.1.2 Europe Pertuzumab Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pertuzumab Market Facts & Figures by Type
7.3 Europe Pertuzumab Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pertuzumab by Region
8.1.1 Asia Pacific Pertuzumab Sales by Region
8.1.2 Asia Pacific Pertuzumab Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pertuzumab Market Facts & Figures by Type
8.3 Asia Pacific Pertuzumab Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pertuzumab by Country
9.1.1 Latin America Pertuzumab Sales by Country
9.1.2 Latin America Pertuzumab Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pertuzumab Market Facts & Figures by Type
9.3 Central & South America Pertuzumab Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pertuzumab by Country
10.1.1 Middle East and Africa Pertuzumab Sales by Country
10.1.2 Middle East and Africa Pertuzumab Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pertuzumab Market Facts & Figures by Type
10.3 Middle East and Africa Pertuzumab Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description, Business Overview and Total Revenue
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Pertuzumab Products Offered
11.1.5 Novartis AG Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Pertuzumab Products Offered
11.2.5 Pfizer Recent Development
11.3 Abnova Corporation
11.3.1 Abnova Corporation Corporation Information
11.3.2 Abnova Corporation Description, Business Overview and Total Revenue
11.3.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abnova Corporation Pertuzumab Products Offered
11.3.5 Abnova Corporation Recent Development
11.4 InvivoGen
11.4.1 InvivoGen Corporation Information
11.4.2 InvivoGen Description, Business Overview and Total Revenue
11.4.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 InvivoGen Pertuzumab Products Offered
11.4.5 InvivoGen Recent Development
11.5 Celltrion
11.5.1 Celltrion Corporation Information
11.5.2 Celltrion Description, Business Overview and Total Revenue
11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celltrion Pertuzumab Products Offered
11.5.5 Celltrion Recent Development
11.6 Biocon Limited
11.6.1 Biocon Limited Corporation Information
11.6.2 Biocon Limited Description, Business Overview and Total Revenue
11.6.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biocon Limited Pertuzumab Products Offered
11.6.5 Biocon Limited Recent Development
11.7 Bio-Techne
11.7.1 Bio-Techne Corporation Information
11.7.2 Bio-Techne Description, Business Overview and Total Revenue
11.7.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bio-Techne Pertuzumab Products Offered
11.7.5 Bio-Techne Recent Development
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Description, Business Overview and Total Revenue
11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis AG Pertuzumab Products Offered
11.1.5 Novartis AG Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pertuzumab Market Estimates and Projections by Region
12.1.1 Global Pertuzumab Sales Forecast by Regions 2021-2026
12.1.2 Global Pertuzumab Revenue Forecast by Regions 2021-2026
12.2 North America Pertuzumab Market Size Forecast (2021-2026)
12.2.1 North America: Pertuzumab Sales Forecast (2021-2026)
12.2.2 North America: Pertuzumab Revenue Forecast (2021-2026)
12.2.3 North America: Pertuzumab Market Size Forecast by Country (2021-2026)
12.3 Europe Pertuzumab Market Size Forecast (2021-2026)
12.3.1 Europe: Pertuzumab Sales Forecast (2021-2026)
12.3.2 Europe: Pertuzumab Revenue Forecast (2021-2026)
12.3.3 Europe: Pertuzumab Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pertuzumab Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pertuzumab Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pertuzumab Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pertuzumab Market Size Forecast by Region (2021-2026)
12.5 Latin America Pertuzumab Market Size Forecast (2021-2026)
12.5.1 Latin America: Pertuzumab Sales Forecast (2021-2026)
12.5.2 Latin America: Pertuzumab Revenue Forecast (2021-2026)
12.5.3 Latin America: Pertuzumab Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pertuzumab Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pertuzumab Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pertuzumab Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pertuzumab Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pertuzumab Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pertuzumab Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pertuzumab Market Segments
Table 2. Ranking of Global Top Pertuzumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pertuzumab Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Human Source
Table 5. Major Manufacturers of Animal Source
Table 6. COVID-19 Impact Global Market: (Four Pertuzumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pertuzumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pertuzumab Players to Combat Covid-19 Impact
Table 11. Global Pertuzumab Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Pertuzumab Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pertuzumab Sales by Regions 2015-2020 (K MT)
Table 14. Global Pertuzumab Sales Market Share by Regions (2015-2020)
Table 15. Global Pertuzumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pertuzumab Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Pertuzumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Pertuzumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2019)
Table 20. Pertuzumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pertuzumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pertuzumab Price (2015-2020) (USD/MT)
Table 23. Pertuzumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pertuzumab Product Type
Table 25. Date of International Manufacturers Enter into Pertuzumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pertuzumab Sales by Type (2015-2020) (K MT)
Table 28. Global Pertuzumab Sales Share by Type (2015-2020)
Table 29. Global Pertuzumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pertuzumab Revenue Share by Type (2015-2020)
Table 31. Pertuzumab Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pertuzumab Sales by Application (2015-2020) (K MT)
Table 33. Global Pertuzumab Sales Share by Application (2015-2020)
Table 34. North America Pertuzumab Sales by Country (2015-2020) (K MT)
Table 35. North America Pertuzumab Sales Market Share by Country (2015-2020)
Table 36. North America Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pertuzumab Revenue Market Share by Country (2015-2020)
Table 38. North America Pertuzumab Sales by Type (2015-2020) (K MT)
Table 39. North America Pertuzumab Sales Market Share by Type (2015-2020)
Table 40. North America Pertuzumab Sales by Application (2015-2020) (K MT)
Table 41. North America Pertuzumab Sales Market Share by Application (2015-2020)
Table 42. Europe Pertuzumab Sales by Country (2015-2020) (K MT)
Table 43. Europe Pertuzumab Sales Market Share by Country (2015-2020)
Table 44. Europe Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pertuzumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Pertuzumab Sales by Type (2015-2020) (K MT)
Table 47. Europe Pertuzumab Sales Market Share by Type (2015-2020)
Table 48. Europe Pertuzumab Sales by Application (2015-2020) (K MT)
Table 49. Europe Pertuzumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pertuzumab Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Pertuzumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pertuzumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pertuzumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pertuzumab Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Pertuzumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pertuzumab Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Pertuzumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Pertuzumab Sales by Country (2015-2020) (K MT)
Table 59. Latin America Pertuzumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pertuzumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pertuzumab Sales by Type (2015-2020) (K MT)
Table 63. Latin America Pertuzumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Pertuzumab Sales by Application (2015-2020) (K MT)
Table 65. Latin America Pertuzumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pertuzumab Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Pertuzumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pertuzumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pertuzumab Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Pertuzumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pertuzumab Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Pertuzumab Sales Market Share by Application (2015-2020)
Table 74. Novartis AG Corporation Information
Table 75. Novartis AG Description and Major Businesses
Table 76. Novartis AG Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novartis AG Product
Table 78. Novartis AG Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Abnova Corporation Corporation Information
Table 85. Abnova Corporation Description and Major Businesses
Table 86. Abnova Corporation Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Abnova Corporation Product
Table 88. Abnova Corporation Recent Development
Table 89. InvivoGen Corporation Information
Table 90. InvivoGen Description and Major Businesses
Table 91. InvivoGen Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. InvivoGen Product
Table 93. InvivoGen Recent Development
Table 94. Celltrion Corporation Information
Table 95. Celltrion Description and Major Businesses
Table 96. Celltrion Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Celltrion Product
Table 98. Celltrion Recent Development
Table 99. Biocon Limited Corporation Information
Table 100. Biocon Limited Description and Major Businesses
Table 101. Biocon Limited Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Biocon Limited Product
Table 103. Biocon Limited Recent Development
Table 104. Bio-Techne Corporation Information
Table 105. Bio-Techne Description and Major Businesses
Table 106. Bio-Techne Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Bio-Techne Product
Table 108. Bio-Techne Recent Development
Table 109. Global Pertuzumab Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Pertuzumab Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Pertuzumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Pertuzumab Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Pertuzumab Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Pertuzumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Pertuzumab Players
Table 127. Pertuzumab Customers List
Table 128. Pertuzumab Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Pertuzumab Market Segments
Table 2. Ranking of Global Top Pertuzumab Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pertuzumab Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Human Source
Table 5. Major Manufacturers of Animal Source
Table 6. COVID-19 Impact Global Market: (Four Pertuzumab Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pertuzumab Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pertuzumab Players to Combat Covid-19 Impact
Table 11. Global Pertuzumab Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Pertuzumab Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pertuzumab Sales by Regions 2015-2020 (K MT)
Table 14. Global Pertuzumab Sales Market Share by Regions (2015-2020)
Table 15. Global Pertuzumab Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pertuzumab Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Pertuzumab Sales Share by Manufacturers (2015-2020)
Table 18. Global Pertuzumab Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertuzumab as of 2019)
Table 20. Pertuzumab Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pertuzumab Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pertuzumab Price (2015-2020) (USD/MT)
Table 23. Pertuzumab Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pertuzumab Product Type
Table 25. Date of International Manufacturers Enter into Pertuzumab Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pertuzumab Sales by Type (2015-2020) (K MT)
Table 28. Global Pertuzumab Sales Share by Type (2015-2020)
Table 29. Global Pertuzumab Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pertuzumab Revenue Share by Type (2015-2020)
Table 31. Pertuzumab Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pertuzumab Sales by Application (2015-2020) (K MT)
Table 33. Global Pertuzumab Sales Share by Application (2015-2020)
Table 34. North America Pertuzumab Sales by Country (2015-2020) (K MT)
Table 35. North America Pertuzumab Sales Market Share by Country (2015-2020)
Table 36. North America Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pertuzumab Revenue Market Share by Country (2015-2020)
Table 38. North America Pertuzumab Sales by Type (2015-2020) (K MT)
Table 39. North America Pertuzumab Sales Market Share by Type (2015-2020)
Table 40. North America Pertuzumab Sales by Application (2015-2020) (K MT)
Table 41. North America Pertuzumab Sales Market Share by Application (2015-2020)
Table 42. Europe Pertuzumab Sales by Country (2015-2020) (K MT)
Table 43. Europe Pertuzumab Sales Market Share by Country (2015-2020)
Table 44. Europe Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pertuzumab Revenue Market Share by Country (2015-2020)
Table 46. Europe Pertuzumab Sales by Type (2015-2020) (K MT)
Table 47. Europe Pertuzumab Sales Market Share by Type (2015-2020)
Table 48. Europe Pertuzumab Sales by Application (2015-2020) (K MT)
Table 49. Europe Pertuzumab Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pertuzumab Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Pertuzumab Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pertuzumab Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pertuzumab Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pertuzumab Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Pertuzumab Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pertuzumab Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Pertuzumab Sales Market Share by Application (2015-2020)
Table 58. Latin America Pertuzumab Sales by Country (2015-2020) (K MT)
Table 59. Latin America Pertuzumab Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pertuzumab Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pertuzumab Sales by Type (2015-2020) (K MT)
Table 63. Latin America Pertuzumab Sales Market Share by Type (2015-2020)
Table 64. Latin America Pertuzumab Sales by Application (2015-2020) (K MT)
Table 65. Latin America Pertuzumab Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pertuzumab Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Pertuzumab Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pertuzumab Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pertuzumab Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pertuzumab Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Pertuzumab Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pertuzumab Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Pertuzumab Sales Market Share by Application (2015-2020)
Table 74. Novartis AG Corporation Information
Table 75. Novartis AG Description and Major Businesses
Table 76. Novartis AG Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novartis AG Product
Table 78. Novartis AG Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Abnova Corporation Corporation Information
Table 85. Abnova Corporation Description and Major Businesses
Table 86. Abnova Corporation Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Abnova Corporation Product
Table 88. Abnova Corporation Recent Development
Table 89. InvivoGen Corporation Information
Table 90. InvivoGen Description and Major Businesses
Table 91. InvivoGen Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. InvivoGen Product
Table 93. InvivoGen Recent Development
Table 94. Celltrion Corporation Information
Table 95. Celltrion Description and Major Businesses
Table 96. Celltrion Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Celltrion Product
Table 98. Celltrion Recent Development
Table 99. Biocon Limited Corporation Information
Table 100. Biocon Limited Description and Major Businesses
Table 101. Biocon Limited Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Biocon Limited Product
Table 103. Biocon Limited Recent Development
Table 104. Bio-Techne Corporation Information
Table 105. Bio-Techne Description and Major Businesses
Table 106. Bio-Techne Pertuzumab Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Bio-Techne Product
Table 108. Bio-Techne Recent Development
Table 109. Global Pertuzumab Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Pertuzumab Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Pertuzumab Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Pertuzumab Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Pertuzumab Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Pertuzumab Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Pertuzumab Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Pertuzumab Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Pertuzumab Players
Table 127. Pertuzumab Customers List
Table 128. Pertuzumab Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pertuzumab Product Picture
Figure 2. Global Pertuzumab Sales Market Share by Type in 2020 & 2026
Figure 3. Human Source Product Picture
Figure 4. Animal Source Product Picture
Figure 5. Global Pertuzumab Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Medical Center
Figure 8. Pertuzumab Report Years Considered
Figure 9. Global Pertuzumab Market Size 2015-2026 (US$ Million)
Figure 10. Global Pertuzumab Sales 2015-2026 (K MT)
Figure 11. Global Pertuzumab Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pertuzumab Sales Market Share by Region (2015-2020)
Figure 13. Global Pertuzumab Sales Market Share by Region in 2019
Figure 14. Global Pertuzumab Revenue Market Share by Region (2015-2020)
Figure 15. Global Pertuzumab Revenue Market Share by Region in 2019
Figure 16. Global Pertuzumab Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pertuzumab Revenue in 2019
Figure 18. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pertuzumab Sales Market Share by Type (2015-2020)
Figure 20. Global Pertuzumab Sales Market Share by Type in 2019
Figure 21. Global Pertuzumab Revenue Market Share by Type (2015-2020)
Figure 22. Global Pertuzumab Revenue Market Share by Type in 2019
Figure 23. Global Pertuzumab Market Share by Price Range (2015-2020)
Figure 24. Global Pertuzumab Sales Market Share by Application (2015-2020)
Figure 25. Global Pertuzumab Sales Market Share by Application in 2019
Figure 26. Global Pertuzumab Revenue Market Share by Application (2015-2020)
Figure 27. Global Pertuzumab Revenue Market Share by Application in 2019
Figure 28. North America Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pertuzumab Sales Market Share by Country in 2019
Figure 31. North America Pertuzumab Revenue Market Share by Country in 2019
Figure 32. U.S. Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pertuzumab Market Share by Type in 2019
Figure 37. North America Pertuzumab Market Share by Application in 2019
Figure 38. Europe Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pertuzumab Sales Market Share by Country in 2019
Figure 41. Europe Pertuzumab Revenue Market Share by Country in 2019
Figure 42. Germany Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pertuzumab Market Share by Type in 2019
Figure 53. Europe Pertuzumab Market Share by Application in 2019
Figure 54. Asia Pacific Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pertuzumab Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pertuzumab Revenue Market Share by Region in 2019
Figure 58. China Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pertuzumab Market Share by Type in 2019
Figure 81. Asia Pacific Pertuzumab Market Share by Application in 2019
Figure 82. Latin America Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pertuzumab Sales Market Share by Country in 2019
Figure 85. Latin America Pertuzumab Revenue Market Share by Country in 2019
Figure 86. Mexico Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pertuzumab Market Share by Type in 2019
Figure 93. Latin America Pertuzumab Market Share by Application in 2019
Figure 94. Middle East and Africa Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pertuzumab Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pertuzumab Revenue Market Share by Country in 2019
Figure 98. Turkey Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pertuzumab Market Share by Type in 2019
Figure 105. Middle East and Africa Pertuzumab Market Share by Application in 2019
Figure 106. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Pertuzumab Product Picture
Figure 2. Global Pertuzumab Sales Market Share by Type in 2020 & 2026
Figure 3. Human Source Product Picture
Figure 4. Animal Source Product Picture
Figure 5. Global Pertuzumab Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Medical Center
Figure 8. Pertuzumab Report Years Considered
Figure 9. Global Pertuzumab Market Size 2015-2026 (US$ Million)
Figure 10. Global Pertuzumab Sales 2015-2026 (K MT)
Figure 11. Global Pertuzumab Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pertuzumab Sales Market Share by Region (2015-2020)
Figure 13. Global Pertuzumab Sales Market Share by Region in 2019
Figure 14. Global Pertuzumab Revenue Market Share by Region (2015-2020)
Figure 15. Global Pertuzumab Revenue Market Share by Region in 2019
Figure 16. Global Pertuzumab Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pertuzumab Revenue in 2019
Figure 18. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pertuzumab Sales Market Share by Type (2015-2020)
Figure 20. Global Pertuzumab Sales Market Share by Type in 2019
Figure 21. Global Pertuzumab Revenue Market Share by Type (2015-2020)
Figure 22. Global Pertuzumab Revenue Market Share by Type in 2019
Figure 23. Global Pertuzumab Market Share by Price Range (2015-2020)
Figure 24. Global Pertuzumab Sales Market Share by Application (2015-2020)
Figure 25. Global Pertuzumab Sales Market Share by Application in 2019
Figure 26. Global Pertuzumab Revenue Market Share by Application (2015-2020)
Figure 27. Global Pertuzumab Revenue Market Share by Application in 2019
Figure 28. North America Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pertuzumab Sales Market Share by Country in 2019
Figure 31. North America Pertuzumab Revenue Market Share by Country in 2019
Figure 32. U.S. Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pertuzumab Market Share by Type in 2019
Figure 37. North America Pertuzumab Market Share by Application in 2019
Figure 38. Europe Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pertuzumab Sales Market Share by Country in 2019
Figure 41. Europe Pertuzumab Revenue Market Share by Country in 2019
Figure 42. Germany Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pertuzumab Market Share by Type in 2019
Figure 53. Europe Pertuzumab Market Share by Application in 2019
Figure 54. Asia Pacific Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pertuzumab Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pertuzumab Revenue Market Share by Region in 2019
Figure 58. China Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pertuzumab Market Share by Type in 2019
Figure 81. Asia Pacific Pertuzumab Market Share by Application in 2019
Figure 82. Latin America Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pertuzumab Sales Market Share by Country in 2019
Figure 85. Latin America Pertuzumab Revenue Market Share by Country in 2019
Figure 86. Mexico Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pertuzumab Market Share by Type in 2019
Figure 93. Latin America Pertuzumab Market Share by Application in 2019
Figure 94. Middle East and Africa Pertuzumab Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Pertuzumab Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pertuzumab Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pertuzumab Revenue Market Share by Country in 2019
Figure 98. Turkey Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pertuzumab Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Pertuzumab Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pertuzumab Market Share by Type in 2019
Figure 105. Middle East and Africa Pertuzumab Market Share by Application in 2019
Figure 106. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Pertuzumab Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Pertuzumab Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
